"The abilities of TSAHC to inhibit phenacetin Odeethylation (CYP1A2), coumarin 6 hydroxylation (CYP2A6), bupropion hydroxylation (CYP2B6), amodiaquine Ndeethylation (CYP2C8), diclofenac 4 hydroxylation (CYP2C9), omeprazole 5 hydroxylation (CYP2C19), dextromethorphan O demethylation (CYP2D6), chlorzoxazone 6 hydroxylation (CYP2E1), and midazolam 1 '-hydroxylation (CYP3A) were tested using human liver microsomes."